A New Era of Obesity Treatment
A combination GIP and GLP-1 receptor could be the next groundbreaking treatment option for people with overweight or obesity, researchers reported. The first-of-its-kind class of combination drug was approved by the U.S. Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes (T2D), but a new study suggests that it […]
Prediabetes: A Dangerous Precursor
More than 88 million adults in the U.S. have prediabetes, a condition that not only increases the risk of developing type 2 diabetes, but also has profound health impacts that can complicate other cardiometabolic diseases. What is prediabetes? As with type 2 diabetes (T2D), prediabetes increases the risk for atherosclerotic cardiovascular disease (ASCVD), nephropathy, retinopathy, […]
